In a study entitled “A gender gap in primary and secondary heart dysfunctions in systemic sclerosis:…
Patricia Inácio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inácio, PhD
In a recent study entitled “Accuracy of invasive arterial pressure monitoring in cardiovascular patients: an observational…
In a study entitled “Oxygen kinetics during 6-minute walk tests in patients with cardiovascular and pulmonary…
A new study entitled “Rho-kinase Mediates Right Ventricular Systolic Dysfunction in Rats with Chronic Neonatal Pulmonary…
Exercise and fitness are two health factors that invariably affect prognoses for most chronic, progressive diseases. Given the stress…
A new study entitled “Quality of life as a prognostic marker in pulmonary arterial hypertension” published…
The results from the randomized controlled AMBITION study to determine the efficacy of treating patients with Pulmonary Arterial Hypertension…
Scientists continue to research the various environmental and lifestyle risk factors associated with PAH. Now, new research is revealing…
A new study entitled “mTORC1 Is Involved in Hypoxia-Induced Pulmonary Hypertension Through the Activation of Notch3”…
A new study entitled “Improved survival of Korean patients with idiopathic pulmonary arterial hypertension after the introduction of targeted therapies” published in August issue of the Heart & Lung journal reports targeted therapies for treatment of idiopathic pulmonary arterial hypertension (IPAH) significantly improve IPAH patients’ survival. IPAH is a serious condition characterized by increased blood pressure in pulmonary arteries, frequently culminating in heart failure. Despite several approved…
A new study, entitled “Frequency of Supraventricular Arrhythmias in Patients With Idiopathic Pulmonary Arterial Hypertension” published…
New research suggests administering molecular Hydrogen, an antioxidant, orally via Hydrogen water may offer therapeutic value to Pulmonary Hypertension…